1 / 25

Prof. Mufuta Tshimanga Co-Principal Investigator

PrePex Device for Rapid Scale up of Male Circumcision Programmes in Zimbabwe: Results of 3 Studies. Prof. Mufuta Tshimanga Co-Principal Investigator. Background. Zimbabwe started VMMC programme in mid 2009 P art of a comprehensive HIV prevention programme

amina
Télécharger la présentation

Prof. Mufuta Tshimanga Co-Principal Investigator

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PrePex Device for Rapid Scale up of Male Circumcision Programmes in Zimbabwe:Results of 3 Studies Prof. Mufuta Tshimanga Co-Principal Investigator

  2. Background • Zimbabwe started VMMC programme in mid 2009 • Part of a comprehensive HIV prevention programme • Phased approach with learning phase • Different models of service delivery, integrated, fixed, outreach and mobile services • Target: 1.3 Million , 80% of 13-29age group by 2015, reached 75,000 since inception • MOHCW interested in innovative models to increase scale up of VMMC • MOVE • Adult male circumcision devices, such as PrePex

  3. Trial Phases • Phase 1 - Safety and Efficacy study • Phase 2- RCT surgery vs device • Phase 3 - Field studies • Each phase examines safety and acceptability

  4. Inclusion Criteria • Above 18 years • Agrees to be circumcised by any of the study methods, PrePex or Surgical, accepts study procedures and requirements • HIV sero-negative Procedures • Screening • Psychosocial Interview • Deployment of Device • Removal of Device • Follow-up visits to day 90

  5. Safety Study • One arm, open label, prospective study to assesssafety and efficacy • 53 Men • Overall procedure duration was 11 minutes 33 sec (SD=3.19 min) for deployment and removal • Median time for complete healing was 35 days post device removal • No SAE recorded

  6. Safety Study-Pain Scores

  7. Safety Study Acceptability • All participants were satisfied with the circumcision procedure and the aesthetic result 90 days post-procedure • 55.5% stated the abstinence period as too long

  8. Comparative Study - Design • RCT comparing PrePex (n=160) to Forceps Guided Surgery (n=80) • Compare the surgery and PrePex: • Procedure time • Time to complete healing • Costing

  9. Comparative Study-Results *p<0.001

  10. Ongoing Field Study • One arm, open label, prospective, cohort field study, 600 participants • Assess safety of PrePex when circumcision is performed by nurses • Evaluate PrePex training needs • Evaluate acceptability of PrePex by patients, partners and care givers • Evaluate the effectiveness and cost-effectiveness of the PrePex device

  11. Field Study-Preliminary Results • Recruitment started 9th May, 2012 at 3 study sites • 750 devices were successfully deployed and removed by Nurses • 150 during training phase • Recruitment completed 9th July, 2012 • No SAE recorded • Follow up visits, to end on 16 Oct, 2012

  12. Conclusions • PrePex device is safe to use for MC delivered by physicians and nurses • Pain related to PrePex appears to be minor • Our findings reaffirm and validate similar clinical studies on PrePex done in Rwanda

  13. Investigators • Dr Gerald Gwinji,MBChB, MPH. PS MoHCW, Principal Investigator • Prof Mufuta Tshimanga, MD; Department of Community Medicine, University of Zimbabwe, Co-Principal Investigator • Dr. Tonderai Mangwiro,MMed Urology, Department of Surgery, University of Zimbabwe • Dr. Owen Mugurungi, MBChB, Msc; Director AIDS /TB unit , MoHCW • Dr. Munyaradzi Murwira, MBChB, MPH, Director ZNFPC • Dr. Dan Montano, PhD, Batelle Memorial Institute • Dr. DanutaKasprzyk, PhD, Batelle Memorial Institute • Mrs. Daisy Nyamukapa, Program Officer, UNFPA • Mr. Sinokuthemba Xaba, MC Program Officer, MOHCW • Dr Karin Hatzold, MD, MPH, Deputy Director SRH, HIV &TB, PSI • Dr Christopher Samkange, Director ICHE, College of Health Sciences, University of Zimbabwe

  14. Acknowledgements • MoHCW • ZNFPC • UNFPA • Gates Foundation • PSI • ZiCHIRe

  15. Summary of Scientific Validation and Implementation of PrePex for Non-Surgical Adult Male CircumcisionMUTABAZI VincentRwanda Ministry of Health AIDS 2012 ConferenceJuly 22nd-27th, 2012

  16. Background • Rwanda has a national goal to significantly decrease its HIV incidence rate, by launching a VMMC to reach 2 million adults in 2 years as part of a comprehensive HIV prevention strategy. • WHO TAG recommendation to scale up PrePex MC in Rwanda received in March 2012.

  17. PrePex Innovation • Non Surgical MC • No injected anesthesia • Bloodless procedure • No sutures • No sterile settings • FDA approved, CE Mark

  18. PrePex Placement Procedure

  19. PrePex Removal Procedure

  20. Clinical Roadmap Clinical studies of PrePex were planned using the WHO Evaluation Framework of Adult MC Devices. • PrePex Safety & Efficacy Study - 105 subjects, including first cases of natural detachment by day 15 that was found to be safeVisited onsite by WHO, Gates. Manuscript Published in JAIDS. CROI, AUA • Comparison Study – 144 PrePex/73 SurgeryAudited onsite by WHO, USAID. Manuscript accepted (not yet published) to JAIDS • NursesFeasibility Study – 49 subjects, 6 nurses • Nurses cohort Study – 590 subjects, 10 nursesOral Presentation in ICASA Dec 2011, IAS 2012

  21. PrePex Center of Excellence • 6 physicians and 41 nurses were successfully trained as PrePex operators in Rwanda. • Teams from Zimbabwe were trained by Rwanda. Hosted delegations from Uganda, Botswana, USA and more in 2012. • 1 paper published, 1 accepted, 1 under review and 2 in writing. • PrePex Train the Trainer available to train Sub-Saharan Africa. Gates Foundation to sponsor capacity building for PrePex Center of Excellence.

  22. First Steps Towards Scale-up • Hearts & Hands Campaign (June 2012) – Sponsored by Korean NGO, 6 nurses from Byumba hospital (rural),1,000 successful MC within 3 weeks with a total of 7 mild AEs, (0.7%). The campaign was closely supervised by MoH, physicians and nurses from PrePex Center of Excellence, All AEs gathered and analyzed. • Army Week Campaign (July 2012) – Sponsored by the Rwanda Military Hospital, 7 teams of nurses performed 1,500 procedures within two weeks on 8 rural health centers across the Cyangugu district. Closely supervised for AEs, 6 mild AEs, AE rate 0.4%. • Operational Pilot Demonstration (Q3 2012) – Sponsored by Global Fund and Bill & Melinda Gates Foundation. Defining parameters for scale up and studying removal with one nurse and AE monitoring for scale up. 10,000 clients.

  23. Key Takeaways • SAFE:Very low AE rate demonstrating high safety of PrePex by nurses. 18 related AES from total of 4166 procedures (0.46%) • EASY TO TRAIN: Nurses with no prior knowledge, can be trained in 3 days course to perform Safe, Effective and Efficient MC. Proper supervision is important to ensure safe implementation before releasing to the field. • NATURAL DETACHMENT – a pre-safety study was conducted in March 2009, to alleviate concerns about men not returning for removal. The outcome assured us that PrePex was safe, and would naturally detach for complete circumcision, if men did not come back to the clinic.

  24. Next Steps • Scale up – Q3 2012 Rwanda plans to initiate scale up program • Pilot of 10,000 to inform scale up (Global Fund, Gates) • 2 Million MCs in 2 years • ~150 teams of 2 nurses (full time – 8 hours a day) • 54 procedures per team per day (Placement +Removal) • 4000 MCs Per day (4000 placements 4000 removals) • 250 working days per year • Adolescents study – 10 to 17 years old

  25. Thank You

More Related